Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto
申请人:Arena Pharmaceuticals, Inc.
公开号:EP2292620A2
公开(公告)日:2011-03-09
The present invention relates to certain fused aryl and heteroaryl derivatives of Formula (I) that are modulators of metabolism.
Accordingly, compounds of the present invention are useful in the prophylaxis or treatment of metabolic disorders and complications thereof, such as, diabetes and obesity.
本发明涉及某些可调节新陈代谢的式 (I) 融合芳基和杂芳基衍生物。
因此,本发明的化合物可用于预防或治疗代谢紊乱及其并发症,如糖尿病和肥胖症。